TD Securities set a C$13.00 price objective on Vitalhub (TSE:VHI – Free Report) in a research note released on Friday morning,BayStreet.CA reports. The brokerage currently has a buy rating on the stock.
Separately, Cormark boosted their target price on shares of Vitalhub from C$9.50 to C$10.50 and gave the stock a “buy” rating in a research note on Wednesday, October 2nd.
Get Our Latest Stock Analysis on Vitalhub
Vitalhub Stock Up 5.8 %
Vitalhub Company Profile
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Read More
- Five stocks we like better than Vitalhub
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Disney’s Magic Strategy: Reinventing the House of Mouse
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Volatility in Semis? 3 Stable Alternatives to NVIDIA and SMCI
- Want to Profit on the Downtrend? Downtrends, Explained.
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.